Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

UK: Baird Capital closes continuation fund to support further growth of Blue Matter

Buy Out Nick Herbert -
Baird Capital, the global venture capital, growth equity and private equity investor, has closed an oversubscribed continuation vehicle to support Blue Matter Consulting, a consulting firm serving the life sciences industry from offices in the US and Europe. Ares Secondaries funds led the deal alongside other investors. Baird Capital Global...

Belgium: UCB strengthens in IMIDs with acquisition of IMIDomics’ Patient Insight business

M&A Nick Herbert -
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients Insights business of IMIDomics, a US-based biotechnology company focused on drug discovery for immune-mediated inflammatory diseases (IMIDs). The strategic acquisition provides UCB with direct access to one of the most advanced, deeply curated human datasets in immunology, significantly enhancing the company’s ability to accelerate therapeutic discovery and development. “The acquisition of IMIDomics’ Patient Insight business represents a significant step in our strategy to build the most robust, human data–driven platform in immune mediated...